Our partners successes

For more than a decade, Phesi has helped the industry deliver smarter trials and faster cures, accelerating clinical development and commercialization and enabling patients to benefit sooner from ground breaking drugs.

Contact us
Partner projects

Maximizing clinical and commercial success

We are proud to have supported sponsors in the development of the following drug development processes.

Drug Disease Company
Keytruda Non small cell lung cancer Merck
Besponsa Acute Lymphoblastic leukemia Pfizer
Plegridy Multiple sclerosis Biogen
Adlyxin Acute Coronary disease Sanofi
PREVYMIS Cytomegalovirus Merck
Xofluza Influenza Shionogi

Smarter Trials. Faster Cures. Delivered.

 

Read our case studies to learn how Trial Accelerator™ can simulate clinical trials and generate Digital Patient Profiles and Digital Twins, inform your program and protocol design, and improve country and investigator site performance. 

 

Case studies

Protocol Planning: Inotuzumab Ozogamicin In Acute Lymphoblastic Leukemia (ALL)

Read more other case studies
Contact us

Join the innovative leaders who use Phesi. Schedule a Trial Accelerator demo today.

request demo
Please fill out the form below:

    Please fill out the form below:

    our clients

    Customer experience

    Phesi is on the frontiers of defining clinical development as a science, performing systematic analysis of the clinical trial, clinical protocol, and clinical site space to form hypotheses about what will work and what will not. Through observation and experiment you are applying those learnings to inform new clinical programs or save old ones. Phesi is more than the sum of its parts and the value is in the integration.

    FORMER SVP, GLOBAL CHIEF MEDICAL OFFICER AND US R&D HEAD Sanofi

    Every global R&D leader should know about this and should be testing it within their portfolio.

    senior director, clinical operations Takeda

    Phesi worked with us to show that a particular adaptive trial design would give the best performance. The result was a significantly quicker and cheaper devel­opment time on this priority asset.

    senior director, clinical operations Takeda
    Other services

    Protocol Design and
    Optimization

    read more

    Ongoing Trial
    Support

    read more

    Digital Twin &
    Digital Trial Arm

    read more